Organization (Industry)
Natural Immune Systems Inc. (United States)
ClinicalTrials.gov lists Natural Immune Systems Inc. (United States) as lead sponsor of 25 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.6 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Natural Immune Systems Inc. (United States): 25 lead-sponsored trials and 1 legal-entity registration.
Disease areas (9)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Anxiety Disorders | 2 |
| Pain | 2 |
| Anemia | 1 |
| Chronic Pain | 1 |
| Dyslipidemias | 1 |
Showing 5 of 9 disease areas.
Trials by start year as sponsor or collaborator (12)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 3 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 3 |
| 2021 | 3 |
| 2020 | 3 |
| 2018 | 5 |
| 2017 | 1 |
| 2016 | 1 |
Showing 10 of 12 years.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 20% hit target (n=5) | 29% on time (n=7) |
Journals published in (6)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Journal of ethnopharmacology | 2 |
| Alternative therapies in health and medicine | 1 |
| Journal of agricultural and food chemistry | 1 |
| Journal of food science | 1 |
| Journal of medicinal food | 1 |
Showing 5 of 6 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 2 | 0 | 2015-09-15 |
Organization relationships (1)
| Related organization | Relationship | Evidence |
|---|---|---|
| New Chapter Inc. | Co sponsors trial with | 1 |
Latest dated events (29)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-12-04 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-09-28 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-05-21 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 29 events.
On Scientist.com
Natural Immune Systems Inc. (United States) is listed as a research supplier in the Scientist.com network.
NIS Labs is a contract research laboratory that focuses on innovative, yet practical approaches to Natural Products Research.
We offer customized protocols that include specific assessment of immunomodulatory properties of natural products as well as an array of standardized tests, including antioxidant capacity and anti-inflammatory effects.
We work with cell-based laboratory (in-vitro) tests and perform clinical trials (in-vivo) on the effect of consumption of natural products.
- Website
- nislabs.com
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.
Work with NIS Labs on Scientist.com
For prices, more details, or to contact NIS Labs, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.